Prolonged antigen‐exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Defined particles carrying tightly bound allergens at high density have been suggested as alternatives in allergy vaccination. Carbohydrate based particles (CBP), sized 2 μm, provide a platform for covalent coupling of allergens. Objective: To investigate the mechanisms of antigen presentation by CBP, as well as cellular and humoral responses after vaccination with the major cat allergen Fel d 1, covalently coupled to CBP. Methods: Mice (n = 10/group) were subcutaneously vaccinated with CBP‐rFel d 1, CBP or phosphate buffer saline (PBS) before sensitization with rFel d 1 and challenged with cat dander extract. Fluorescent and 75 Se‐radiolabeled tracking of allergens and particles were performed with flow cytometry and whole‐body autoradiography. Humoral, cellular and regulatory immune responses were analyzed by ELISA and flow cytometry. Cytokines were measured in bronchoalveolar lavage fluid and splenocyte cultures. Results: CBP‐rFel d 1 prevented induction of airway inflammation and induced allergen‐specific T‐cell anergy. CBP‐rFel d 1 also induced rapid IgM and IgG1‐responses compared with soluble rFel d 1. Particles were phagocytosed by antigen‐presenting cells and transported to draining lymph nodes and spleen. Moreover, antigen coupled to CBP remained longer at the injection site compared with alum. Conclusions: Covalent coupling of rFel d 1 to CBP induces rapid antibody production, prevents induction of allergic immune responses and systemic allergen spreading. Thus, CBP comprise several attractive adjuvant features for use in allergy vaccination. Clinical Implications: Prolonged allergen exposure through covalent coupling to particles suitable for phagocytosis, provides an adjuvant for safer and efficient allergy vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microparticle vaccine approaches to stimulate mucosal immunisation
Brayden, D. J., & Baird, A. W. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01445-9 · Cited by 64
Cited by
Therapies for allergic inflammation: refining strategies to induce tolerance
Akdis, C. A. (2012) · Nature Medicine · doi:10.1038/nm.2754 · Cited by 296
Advances in allergen immunotherapy: Aiming for complete tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7390 · Cited by 118
Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation
Silva, A. L., Peres, C., Conniot, J., Matos, A. I., Moura, L., Carreira, B., Sainz, V., Scomparin, A., Satchi-Fainaro, R., Préat, V., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.003 · Cited by 95
mRNA vaccination as a safe approach for specific protection from type I allergy
Weiss, R., Scheiblhofer, S., Roesler, E., Weinberger, E., & Thalhamer, J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.168 · Cited by 42
Metadata
- Authors
- Thunberg, S., Neimert‐Andersson, T., Cheng, Q., Wermeling, F., Bergström, U., Swedin, L., Dahlén, S. ‐., Arnér, E., Scheynius, A., Karlsson, M. C. I., Gafvelin, G., Van Hage, M., & Grönlund, H.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2009-05-11
- Volume
- 64
- Issue
- 6
- Pages
- 919-926
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1963559321
- Cited by
- 43
- References
- 1
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prolonged antigen‐exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice. https://app.cochat.ai/papers/10.1111/j.1398-9995.2008.01905.x
- The paper
- Thunberg, S., Neimert‐Andersson, T., Cheng, Q., Wermeling, F., Bergström, U., Swedin, L., Dahlén, S. ‐., Arnér, E., Scheynius, A., Karlsson, M. C. I., Gafvelin, G., Van Hage, M., & Grönlund, H. (2009). Prolonged antigen‐exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice. Allergy. https://doi.org/10.1111/j.1398-9995.2008.01905.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.